Irritable bowel syndrome at young age: Salofalk treatment efficacy

2018 ◽  
Vol 0 (4) ◽  
pp. 67-73
Author(s):  
A. E. Dorofeyev ◽  
M. M. Rudenko ◽  
Yu. V. Zhigal
Keyword(s):  
Irritable Bowel Syndrome ◽  
Treatment Efficacy ◽  
Young Age ◽  
Irritable Bowel

scholarly journals Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases

2022 ◽  
Vol 31 (5) ◽  
pp. 61-65
Author(s):  
A. A. Sheptulin
Keyword(s):  
Irritable Bowel Syndrome ◽  
Functional Dyspepsia ◽  
Treatment Efficacy ◽  
Gastrointestinal Diseases ◽  
Mechanisms Of Action ◽  
Current Evidence ◽  
Key Points ◽  
Irritable Bowel ◽  
Functional Gastrointestinal Diseases ◽  
Agent Development

Aim. A review of current therapeutic perspectives of the herbal STW 5 medicine (Iberogast®) in functional gastrointestinal (GI) diseases.Key points. A limited remediation in most common functional GI diseases, functional dyspepsia (FD) and irritable bowel syndrome (IBS), is conditioned by their multifactorial pathogenesis. Meanwhile, most specific medicines only target selected pathogenesis components, thus warranting a multitarget agent development. Such is Iberogast® that acts at variant components of FD and IBS pathogenesis. The article reviews the Iberogast® mechanisms of action and evaluates its treatment efficacy in FD and IBS.Conclusion. The current evidence claims that Iberogast® provides an effective and safe treatment for FD and IBS. 

Motor and sensory function of the rectum in different types of irritable bowel syndrome

2001 ◽  
Vol 120 (5) ◽  
pp. A399-A399
Author(s):  
J STEENS ◽  
P SCHAAR ◽  
C LAMERS ◽  
A MASCLEE
Keyword(s):  
Irritable Bowel Syndrome ◽  
Sensory Function ◽  
Different Types ◽  
Irritable Bowel

Rome I versus Rome II; Overlap in patients enrolled in tegaserod phase III clinical trials for irritable bowel syndrome (IBS)

2001 ◽  
Vol 120 (5) ◽  
pp. A284-A284
Author(s):  
B NAULT ◽  
S SUE ◽  
J HEGGLAND ◽  
S GOHARI ◽  
G LIGOZIO ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Irritable Bowel Syndrome ◽  
Phase Iii ◽  
Phase Iii Clinical Trials ◽  
Irritable Bowel ◽  
Rome I

Alterations in regional decreased cerebral blood flow in patients with irritable bowel syndrome-A PET imaging study

2001 ◽  
Vol 120 (5) ◽  
pp. A637-A637
Author(s):  
Y RINGEL ◽  
D DROSSMAN ◽  
T TURKINGTON ◽  
B BRADSHAW ◽  
R COLEMAN ◽  
...  
Keyword(s):  
Blood Flow ◽  
Irritable Bowel Syndrome ◽  
Cerebral Blood Flow ◽  
Pet Imaging ◽  
Imaging Study ◽  
Irritable Bowel

Health releated quality of life in irritable bowel syndrome: A community based study+

2001 ◽  
Vol 120 (5) ◽  
pp. A634-A634 ◽  
Author(s):  
K OLDEN ◽  
W CHEY ◽  
J BOYLE ◽  
E CARTER ◽  
L CHANG
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Community Based ◽  
Irritable Bowel

Differences in productivity QOL, and resource use in newly diagnosed and established irritable bowel syndrome (IBS) patients

2001 ◽  
Vol 120 (5) ◽  
pp. A634-A634
Author(s):  
P JHINGRAN ◽  
J RICCI ◽  
M MARKOWITZ ◽  
S GORDON ◽  
A ASGHARIAN ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Resource Use ◽  
Newly Diagnosed ◽  
Irritable Bowel
Sign in / Sign up

Export Citation Format

Share Document